DE69001107D1 - Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen. - Google Patents

Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen.

Info

Publication number
DE69001107D1
DE69001107D1 DE9090870135T DE69001107T DE69001107D1 DE 69001107 D1 DE69001107 D1 DE 69001107D1 DE 9090870135 T DE9090870135 T DE 9090870135T DE 69001107 T DE69001107 T DE 69001107T DE 69001107 D1 DE69001107 D1 DE 69001107D1
Authority
DE
Germany
Prior art keywords
fatty acid
oxygen
retroviral infections
acid analogs
substituted fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090870135T
Other languages
English (en)
Other versions
DE69001107T2 (de
Inventor
Jeffrey Ivan Gordon
Steven Paul Adams
Robert Otto Heuckeroth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of DE69001107D1 publication Critical patent/DE69001107D1/de
Application granted granted Critical
Publication of DE69001107T2 publication Critical patent/DE69001107T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/60—Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE90870135T 1989-09-01 1990-08-31 Sauerstoff- oder schwefelsubstituierte Fettsäureanaloga zur Behandlung retroviraler Infektionen. Expired - Fee Related DE69001107T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/402,094 US5073571A (en) 1988-06-16 1989-09-01 Method of inhibiting virus

Publications (2)

Publication Number Publication Date
DE69001107D1 true DE69001107D1 (de) 1993-04-22
DE69001107T2 DE69001107T2 (de) 1993-10-07

Family

ID=23590495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90870135T Expired - Fee Related DE69001107T2 (de) 1989-09-01 1990-08-31 Sauerstoff- oder schwefelsubstituierte Fettsäureanaloga zur Behandlung retroviraler Infektionen.

Country Status (8)

Country Link
US (1) US5073571A (de)
EP (1) EP0415902B1 (de)
JP (1) JPH0714875B2 (de)
AT (1) ATE86854T1 (de)
CA (1) CA2024489A1 (de)
DE (1) DE69001107T2 (de)
DK (1) DK0415902T3 (de)
ES (1) ES2055407T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06245775A (ja) * 1990-02-26 1994-09-06 Washington Univ 蛋白質ｎ−ミリストイル化方法
US5236955A (en) * 1992-04-10 1993-08-17 Washington University Anti-fungal agent
US6602861B1 (en) 1992-04-16 2003-08-05 Research Corporation Technologies, Inc. Acylated phospholipid drugs
GB9212276D0 (en) * 1992-06-10 1992-07-22 Harper David R Anti-viral agents
US5463152A (en) * 1994-12-08 1995-10-31 E. I. Du Pont De Nemours And Company Halofluorocarbon hydrogenolysis
GB2267642B (en) * 1992-06-10 1996-04-24 British Tech Group Anti-viral agents
US5859052A (en) * 1993-01-14 1999-01-12 G. D. Searle & Co. Fatty acid analogs and prodrugs
US5599947A (en) * 1993-01-14 1997-02-04 G. D. Searle & Co. Fatty acid analogs and prodrugs
DE10063111A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Replikationsassay zur Auffindung antiviraler Substanzen
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
US9144575B2 (en) 2010-07-28 2015-09-29 Life Technologies Corporation Anti-viral azide containing compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262514A1 (en) * 1974-03-01 1975-09-26 Alary Josette Reticulo-endothelial stimulating compsn. - contg. sodium oleate, sodium stearate and neutralised olive oil
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
US4709012A (en) * 1986-08-07 1987-11-24 Washington University Novel inhibitor peptides
US4740588A (en) * 1986-08-07 1988-04-26 Washington University Novel substrate peptides

Also Published As

Publication number Publication date
ATE86854T1 (de) 1993-04-15
DK0415902T3 (da) 1993-04-19
JPH03109322A (ja) 1991-05-09
ES2055407T3 (es) 1994-08-16
EP0415902A1 (de) 1991-03-06
EP0415902B1 (de) 1993-03-17
CA2024489A1 (en) 1991-03-02
US5073571A (en) 1991-12-17
DE69001107T2 (de) 1993-10-07
JPH0714875B2 (ja) 1995-02-22

Similar Documents

Publication Publication Date Title
FI881646A (fi) Nya fasta icke-nedbrytbara fettliknande foereningar.
HUT47553A (en) Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components
DE3789274D1 (de) Verfahren zur Herstellung von zyklischen Estern hoher Reinheit.
AU2867089A (en) (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active ingredient
DE3868886D1 (de) Fettsaeure-zusammensetzungen.
ATE121939T1 (de) Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion.
DE69224124T2 (de) Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid
DE69001107D1 (de) Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen.
DE58906574D1 (de) Verfahren zur Herstellung von cyclischen Kohlensäureestern.
DE3878313D1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
DE69212925T2 (de) Polymerisationsinhibitoren für Acrylsäure und Ester
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
ES2058201T3 (es) Esteres de castanoespermina en el tratamiento de infecciones retrovirales.
AU631738B2 (en) Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
ES2054480T3 (es) Nuevos sustratos de enzimas, analogos de acidos grasos.
ATE95836T1 (de) Zum abbau von glycosaminoglycan faehige enzymzusammensetzung und verfahren zur herstellung dieser zusammensetzung.
DE69108616D1 (de) 3.3'-Dithiobis (Propionsäuren) und Estern davon.
ES2062282T3 (es) Proceso de racemizacion de esteres del acido carboxilico opticamente activos.
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
DE3784308T2 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
DE68908843T2 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
DE68912504D1 (de) Verfahren zur Herstellung von optisch aktiver beta-Halomilchsäure oder Glycidsäure.
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee